Date:4/29/2010

620.7 597.5 Inventories 215.6 189.7 Deferred tax asset 114.1 135.8 Prepaid expenses and other current assets 131.0 115.2 Total current assets 1,765.7 1,570.2 Non-current assets: Investments 109.6 105.7 Property, plant and equipment, net 668.5 676.8 Goodwill 373.2 384.7 Other intangible assets, net 1,729.6 1,790.7 Deferred tax asset 80.9 79.0 Other non-current assets 11.2 10.4 Total assets 4,738.7 4,617.5 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 929.2 929.1 Deferred tax liability 3.3 2.9 Other current liabilities 36.5 88.0 Total current liabilities 969.0 1,020.0 Non-current liabilities: Convertible bonds 1,100.0 1,100.0 Other long-term debt 43.7 43.6 Deferred tax liability 321.3 294.3 Other non-current liabilities 247.7 247.1 Total liabilities 2,681.7 2,705.0 Shareholders' equity: Common stock of 5p par value; 1,000 million shares authorized; and 562.1 million shares issued and outstanding (2009: 1,000 million shares authorized; and 561.5 million shares issued and outstanding)
'/>"/>

SOURCE Shire plc Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
2. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
3. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
4. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
5. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
6. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
7. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
8. Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
9. EUCODIS Bioscience Launches Lipase Portfolio
10. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
11. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial